Dataset | LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules |
Category | transcriptomics |
Type | small molecule perturbation |
Description | small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit] (LINCS L1000 Connectivity Map) |
Similar Terms | |
Downloads & Tools |
107 genes differentially expressed following the BRD-U64521890_XMD16-144_A549_24_h_3.33_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
Symbol | Name |
---|---|
1060P11.3 | killer cell immunoglobulin-like receptor, three domains, pseudogene |
ADI1 | acireductone dioxygenase 1 |
CCDC85B | coiled-coil domain containing 85B |
CCL20 | chemokine (C-C motif) ligand 20 |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
DDX3Y | DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
DHRS2 | dehydrogenase/reductase (SDR family) member 2 |
DIRAS3 | DIRAS family, GTP-binding RAS-like 3 |
DSP | desmoplakin |
DUSP14 | dual specificity phosphatase 14 |
FABP4 | fatty acid binding protein 4, adipocyte |
FAS | Fas cell surface death receptor |
GPM6B | glycoprotein M6B |
H2BFS | H2B histone family, member S (pseudogene) |
H3F3B | H3 histone, family 3B (H3.3B) |
HIST1H1C | histone cluster 1, H1c |
HIST1H2AC | histone cluster 1, H2ac |
HIST1H2AE | histone cluster 1, H2ae |
HIST1H2BD | histone cluster 1, H2bd |
HIST1H2BE | histone cluster 1, H2be |
HIST1H2BF | histone cluster 1, H2bf |
HIST1H2BG | histone cluster 1, H2bg |
HIST1H2BH | histone cluster 1, H2bh |
HIST1H2BK | histone cluster 1, H2bk |
HIST1H3H | histone cluster 1, H3h |
HIST2H2BE | histone cluster 2, H2be |
HK2 | hexokinase 2 |
HOOK2 | hook microtubule-tethering protein 2 |
KIAA0485 | uncharacterized LOC57235 |
KRT13 | keratin 13, type I |
KRT15 | keratin 15, type I |
N4BP2L2 | NEDD4 binding protein 2-like 2 |
NSG1 | neuron specific gene family member 1 |
PI3 | peptidase inhibitor 3, skin-derived |
PLCB4 | phospholipase C, beta 4 |
PTGDS | prostaglandin D2 synthase 21kDa (brain) |
RAMP1 | receptor (G protein-coupled) activity modifying protein 1 |
S100A7 | S100 calcium binding protein A7 |
SESN1 | sestrin 1 |
SFRP1 | secreted frizzled-related protein 1 |
SLC39A6 | solute carrier family 39 (zinc transporter), member 6 |
SLC5A3 | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
ST7 | suppression of tumorigenicity 7 |
TGFBR3 | transforming growth factor, beta receptor III |
TRA2A | transformer 2 alpha homolog (Drosophila) |
TTC39A | tetratricopeptide repeat domain 39A |
Symbol | Name |
---|---|
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta |
AUTS2 | autism susceptibility candidate 2 |
BCAT1 | branched chain amino-acid transaminase 1, cytosolic |
BGN | biglycan |
C4BPA | complement component 4 binding protein, alpha |
C5 | complement component 5 |
CA12 | carbonic anhydrase XII |
CCL2 | chemokine (C-C motif) ligand 2 |
CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 |
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
CLC | Charcot-Leyden crystal galectin |
COL1A2 | collagen, type I, alpha 2 |
COL4A2 | collagen, type IV, alpha 2 |
COL5A1 | collagen, type V, alpha 1 |
COL5A2 | collagen, type V, alpha 2 |
CPB1 | carboxypeptidase B1 (tissue) |
CST4 | cystatin S |
CXCL14 | chemokine (C-X-C motif) ligand 14 |
FGA | fibrinogen alpha chain |
FGB | fibrinogen beta chain |
FGFR3 | fibroblast growth factor receptor 3 |
FGG | fibrinogen gamma chain |
FXYD5 | FXYD domain containing ion transport regulator 5 |
GATM | glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
GINS2 | GINS complex subunit 2 (Psf2 homolog) |
GJA1 | gap junction protein, alpha 1, 43kDa |
GPER1 | G protein-coupled estrogen receptor 1 |
GREM1 | gremlin 1, DAN family BMP antagonist |
HES1 | hes family bHLH transcription factor 1 |
IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 |
IGFBP5 | insulin-like growth factor binding protein 5 |
IL1R1 | interleukin 1 receptor, type I |
LOX | lysyl oxidase |
LPAR1 | lysophosphatidic acid receptor 1 |
LRRFIP1 | leucine rich repeat (in FLII) interacting protein 1 |
LYZ | lysozyme |
MARCKS | myristoylated alanine-rich protein kinase C substrate |
MEIS2 | Meis homeobox 2 |
MGLL | monoglyceride lipase |
NNMT | nicotinamide N-methyltransferase |
NR2F1 | nuclear receptor subfamily 2, group F, member 1 |
NTS | neurotensin |
POLE2 | polymerase (DNA directed), epsilon 2, accessory subunit |
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
RAD51 | RAD51 recombinase |
RGCC | regulator of cell cycle |
RGS2 | regulator of G-protein signaling 2 |
RRM2 | ribonucleotide reductase M2 |
SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
SLC7A7 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
SNAP25 | synaptosomal-associated protein, 25kDa |
SRGN | serglycin |
SYT1 | synaptotagmin I |
TCF4 | transcription factor 4 |
TFR2 | transferrin receptor 2 |
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 |
TPM4 | tropomyosin 4 |
TSC22D3 | TSC22 domain family, member 3 |
VCAN | versican |
WIPF1 | WAS/WASL interacting protein family, member 1 |
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |